Skip to content
Search

Latest Stories

Smartphone app fares better than face-to-face appointments in obesity fight, study finds

The patients with severe obesity can lose around five per cent of their weight and the most body mass by using a smartphone app rather than attending face-to-face appointments, a new study has showed.

The app, Oviva, is now calling for the NHS to fully embrace digital as a core platform to help people living with obesity or other health conditions in post-Covid world.


In new peer-reviewed research, 169 people living with severe obesity took part in a tier 3 weight management programme for 12-16 weeks.

The programme was commissioned jointly by the NHS and a local authority in West Yorkshire and provided by digital weight management provider Oviva. Participants had a BMI of at least 40 - and were referred onto the programme by their GP.

The key findings of the study include:

  • an overwhelming majority of people (64.5%) opted to join the programme on the app, compared to 28.4 per cent who chose face-to-face participation and 7.1 per cent who opted for over the phone. This was even before Covid-19 hit
  • more than half of patients participating on the app (53%) lost five per cent of their weight. This compares to 47.9 per cent of face-to-face participants and 33 per cent of phone participants
  • app users lost the most body mass - an average of 6.1kg. Face-to-face patients lost a mean of 5.3kg, while those who took part over the phone lost 4kg
  • some three quarters of app users (74 per cent) cut their BMI by 1 unit, compared to 64 per cent of face-to-face participants and 58 per cent for those who took part over the phone.

“Here at Wakefield Council we wanted to incorporate the digital healthcare element into our weight management service as we felt it would improve accessibility and provide a tailored approach for our service users," Cllr Jacquie Speight, Wakefield Council’s Cabinet Member for Culture, Leisure and Sport.

"From our experiences we’ve found not only does it do this, it can also improve adherence and offer a level of flexibility that can only be beneficial for all involved.”

Rosemary Huntriss, who works at Oviva and has been the specialist weight-management dietitian involved in the evaluation, said: "Covid-19 has seen a switch to more people seeing their doctor and managing their conditions remotely - and the past year has shown us that the technology works, it’s convenient, and it has potential to save the NHS vast sums of money,"

“We’d like to see digital care being fully embraced as a core platform alongside face-to-face services within the NHS to support patients living with obesity or other chronic health conditions.”

NHS Digital approved, the Oviva app is available on the NHS App Library.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less